Skip to main content
Top
Published in: Medical Oncology 6/2014

01-06-2014 | Original Paper

Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer

Authors: William Whitney Robertson, Matthew A. Steliga, Eric R. Siegel, Konstantinos Arnaoutakis

Published in: Medical Oncology | Issue 6/2014

Login to get access

Abstract

Management of advanced non-small cell lung cancer patients is dependent on the histologic diagnosis for both testing and treatment. This study was designed to determine the ability of fine needle aspiration and core biopsies to correctly determine histologic diagnosis in non-small cell lung cancer. Our institutional cardiothoracic surgery database was reviewed for cases of non-small cell lung cancer treated with lobectomy after a preoperative biopsy by CT guidance or bronchoscopy over a 10-year period from 2002 to 2011. The histologic diagnosis of the final lobectomy specimen was compared to the histologic diagnosis from the preoperative biopsy, and the concordance rate was calculated. 119 biopsy specimens from 117 patients were reviewed. Eighty of the 119 biopsies had the same histologic diagnosis as the lobectomy specimen, yielding an overall concordance rate of 67.2 %. Patients with poorly differentiated tumors were at the highest risk of an incorrect histologic diagnosis on preoperative biopsy. Reliance on fine needle aspiration and core biopsies to determine histologic diagnosis in non-small cell lung cancer may put some patients at risk for suboptimal treatment.
Literature
1.
go back to reference American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011. American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011.
2.
go back to reference Johnson D, et al. Randomized phase ii trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously treated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91.PubMedCrossRef Johnson D, et al. Randomized phase ii trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously treated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91.PubMedCrossRef
3.
go back to reference Scagliotti G, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy naïve patients with advanced stage non-small cell lung cancer. J Clin Oncol. 2008;26(21):3543–51.PubMedCrossRef Scagliotti G, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy naïve patients with advanced stage non-small cell lung cancer. J Clin Oncol. 2008;26(21):3543–51.PubMedCrossRef
5.
go back to reference Yilmaz A, et al. Cell type accuracy of transthoracic fine needle aspiration material in primary lung cancer. Respirology. 2001;6:91–4.PubMedCrossRef Yilmaz A, et al. Cell type accuracy of transthoracic fine needle aspiration material in primary lung cancer. Respirology. 2001;6:91–4.PubMedCrossRef
6.
go back to reference Fassina A, et al. Role and accuracy of rapid on-site evaluation of CT guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–12.PubMedCrossRef Fassina A, et al. Role and accuracy of rapid on-site evaluation of CT guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–12.PubMedCrossRef
7.
go back to reference Lindeman N, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. J Thorac Oncol. 2013;8:823–59.PubMedCrossRef Lindeman N, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. J Thorac Oncol. 2013;8:823–59.PubMedCrossRef
8.
go back to reference Travis W, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRef Travis W, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRef
Metadata
Title
Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer
Authors
William Whitney Robertson
Matthew A. Steliga
Eric R. Siegel
Konstantinos Arnaoutakis
Publication date
01-06-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 6/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0967-7

Other articles of this Issue 6/2014

Medical Oncology 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.